Clinically Significant Drug Interactions with Antituberculosis Agents
- 期刊名称Drug Safety
- 作者Dr John M. Grange,Peter A. Winstanley,Peter D. O. Davies
- 卷第11卷
- 期第4期
- 印刷ISSN0114-5916
- 电子ISSN1179-1942
- 文件大小1525.66KB
- 发表时间1994-10
- DOI10.2165/00002018-199411040-00003
- 页码242-251
Nicotinic acid: clinical considerationsKei, Anastazia; Elisaf, Moses S · Expert Opinion on Drug Safety · 2012
Drug safety evaluation of rosuvastatinToth, Peter P; Dayspring, Thomas D · Expert Opinion on Drug Safety · 2011
Gastrointestinal side effects of drugsMakins, Richard; Ballinger, Anne · Expert Opinion on Drug Safety · 2003
Capecitabine and hand–foot syndromeSaif, Muhammad Wasif · Expert Opinion on Drug Safety · 2011
Immune hemolytic anemia caused by drugsGarratty, George · Expert Opinion on Drug Safety · 2012
Benfluorex-induced cardiac valve injuryAcar, Jean · Pharmacoepidemiology and Drug Safety · 2012
Extrapyramidal Symptoms with Atypical AntipsychoticsPierre, Joseph M · Drug Safety · 2005
Tolerability of ParacetamolGraham, Garry G; Scott, Kieran F; Day, Richard O · Drug Safety · 2005